olopatadine hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
45802-104 -
Package NDC
45802-104-01 -
Application number
ANDA202853 -
SPL ID
dca15bfb-d84a-46e3-800c-3e3e1eaa6967 -
SPL set ID
126ff6eb-62ae-46f2-ab1e-7ac19346c36b -
UNII
2XG66W44KF -
RxCUI
1797895
What the source publishes
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Active ingredients
- Olopatadine Hydrochloride
- Form
- SPRAY
- Routes
- NASAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "olopatadine hydrochloride",
"splId": "dca15bfb-d84a-46e3-800c-3e3e1eaa6967",
"labels": [
{
"setId": "126ff6eb-62ae-46f2-ab1e-7ac19346c36b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=126ff6eb-62ae-46f2-ab1e-7ac19346c36b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=126ff6eb-62ae-46f2-ab1e-7ac19346c36b"
}
],
"routes": [
"NASAL"
],
"labeler": "Padagis Israel Pharmaceuticals Ltd",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE",
"package_ndc": "45802-104-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20170614"
}
],
"productId": "45802-104_dca15bfb-d84a-46e3-800c-3e3e1eaa6967",
"useDomain": "unknown",
"dosageForm": "SPRAY",
"productNdc": "45802-104",
"deaSchedule": null,
"genericName": "Olopatadine Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OLOPATADINE HYDROCHLORIDE",
"strength": "665 ug/1"
}
],
"applicationNumber": "ANDA202853",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170614",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"2XG66W44KF"
],
"rxcui": [
"1797895"
],
"spl_set_id": [
"126ff6eb-62ae-46f2-ab1e-7ac19346c36b"
],
"manufacturer_name": [
"Padagis Israel Pharmaceuticals Ltd"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:45802-104_dca15bfb-d84a-46e3-800c-3e3e1eaa6967"